The local Commercial Head of a tier II global pharma company could not retain talent, and team turnover was >50% YoY. Operations were resented, as well as business results.
Switzerland: Go/ no-go decision launch of Rx product and OTC extension.
The local management of a tier-1 global pharma company wanted to understand the interest and sustainability of launching a Rx retail product in Switzerland, potentially an OTC line extension of the same product, and the impact on their own local product portfolio.
The Regional management of a global tier 2 pharmaceutical company had noticed a gap on the skills and capabilities of the Central European team, recently joining through the acquisition of a local company. Regional HR required BUM / GM coaching on specific operational area skills.
‘ Zarzia provided an energetic, engaging training with a great depth of knowledge and a raft of interesting anecdotes with which to bring the subject to life.’ SFE & planning director, Southern Europe (Balkans)
Find us on:
EU e-Privacy Directive
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.